Norepinephrine bitartrate injection is indicated to raise blood pressure in adult patients with acute hypotension.

US Food and Drug Administration (US FDA) for its ANDA Norepinephrine Bitartrate Injection USP, 4 mg/4 mL (1 mg/mL) ...

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

Bengaluru: Biocon has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received approval ...

Norepinephrine bitartrate injection is a critical medication used to raise blood pressure in adult patients suffering from ...

The approval covers the norepinephrine bitartrate injection 4 mg/4 mL (1 mg/mL) single-dose vial, which can now be ...

Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...

Biocon added 1.34% to Rs 348.55 after the company's wholly owned subsidiary Biocon Pharma announced the receipt of U.S Food and Drug Administration (US FDA) approval for its ANDA Norepinephrine ...

Image Source: Zacks Investment Research Baxter launched a new 16 mg/250 mL dosage of Norepinephrine Bitartrate in 5% Dextrose injection, which is recommended for adult patients with severe ...